100
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communication

Secondary metabolites from Pometia pinnata leaves

, , , , , , & show all
Received 12 Sep 2024, Accepted 29 May 2025, Published online: 07 Jun 2025
 

Abstract

A new hederagenin glycoside, named pometin B [3-O-(5’’’-O-acetyl-α-L-arabinofuranosyl)-(1’’’→3’)-[α-L-rhamnopyranosyl-(1’’→2’)]-β-L-arabinopyranosyl hederagenin] (1), was isolated from Pometia pinnata leaves along with known compounds, including stigmasterol-3-O-α-glucoside (2), kaempferol-3-O-α-rhamnoside (3), quercetin-3-O-α-rhamnoside (4), and proanthocyanidin A2 (5). The chemical structures of these compounds were confirmed through detailed analysis of 1D and 2D NMR spectra, supported by mass spectrometry data. The identities of known compounds were further verified by comparison with the corresponding data in the literature. Compound 1 exhibited notable cytotoxic activity against the MCF7 cell line with the IC50 value of 3.69 μg/mL. Compounds 3-5 showed significant antioxidant and alpha-glucosidase inhibitory activities.

Graphical Abstract

Acknowledgements

We acknowledge Integrated Chemistry Laboratory, Faculty of Mathematics and Natural Sciences, Bandung Institute of Technology for facilitating the measurements of NMR and HR-MS spectroscopy data.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was funded by the Penelitian Fundamental Reguler 2023 Program granted by the Directorate of Research, Technology, and Community Service under the Ministry of Education, Culture, Research, and Technology of the Republic of Indonesia [110/E5/PG.02.00.PL/2023; 298/IT1.B07.1/SPP-LPPM/VI/2023].

Please note: Selecting permissions does not provide access to the full text of the article,
please see our help page How do I view content?

Academic Permissions

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Corporate Permissions

To request corporate permissions for this article, please click on the button below:

Reprints

To request a reprint for this article, please click on the button below: